MLA medical australia limited

quiet here, page-9

  1. 281 Posts.
    lightbulb Created with Sketch. 40
    No real surprises from my side in annual report.

    Cash burn a little lower but this is explained by increase in current creditors which will reverse next quater.

    Cost of legal case higher than I thought so a small positive as this should not be repeated.

    If mla can match first quarter sales from sept 2011 this quater I would view positively given previous one off's in 2011 i.e flat result would be consistent with managements sales growth forecast in going concern statement. If they beat it then would become more optimistic.

    Given mkt reaction since annual report I'm more comfortable that share price low was already in place when I responded to Wiegan on August 28.

    As to the need for a further capital raising commented in threads in August,, this would appear to have reduced given not included in going concern statements. Obviously this can change depending on sales in next couple of quarters so will wait and see.

    As always DYOR , IMHO etc, etc
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.